Tamoxifen has a proliferative effect in endometrial carcinoma mediated via the GPER/EGFR/ERK/cyclin D1 pathway: A retrospective study and an in vitro studyLizhi Zhang, Ke Wen, Yanmin Li et al.|Molecular and Cellular Endocrinology|2016Cited by 32
Advanced Pelvic Malignancy Causes Syndrome of Inappropriate Antidiuretic Hormone Secretion: A Case ReportLong Xiaolin, Quanxin Qu, L Fenge et al.|Journal of Gynecological Oncology|2020Cited by 0
Front & Back MatterPaweł Krawczyk, Gabriel Benz, Kinga Winiarczyk et al.|Chemotherapy|2012Cited by 0